Hepatology
FDA/CDC
Some HCV medications associated with serious liver injury
In many cases, the medications should never have been prescribed, according to the FDA.
Latest News
USPSTF issues draft recommendation statement for HCV screening in adults
The proposal represents an update and expansion of USPSTF’s current recommendation.
News
Treatment for hepatitis C reduces risk of Parkinson’s disease
Data support the hypothesis that hepatitis C virus infection is a risk factor for incident Parkinson’s disease.
News
Despite HCV cure, liver cancer-associated genetic changes persist
News
For patients with end-stage liver disease, acute care incurs steep costs
Mean end-of-life costs exceeded those for ischemic heart disease, diabetes, mental health disorders, and congestive heart failure. Only chronic...
News
Developing an HCV vaccine faces significant challenges
Conference Coverage
It’s time for universal HCV screening in the ED
SAN FRANCISCO –
Conference Coverage
U.S. death rates from chronic liver disease continue to rise
Rising mortality from chronic liver disease likely driven by an increase in obesity and type 2 diabetes.
Conference Coverage
ACIP votes unanimously in favor of immunization schedule update and redesign
News
Cirrhosis study finds no link between screening, liver cancer mortality
Among patients with cirrhosis, screening for hepatocellular carcinoma was not associated with reductions in liver cancer mortality.